Role of Primary Care in the Prevention of Malignant Melanoma

Overview

Journal Br J Gen Pract

Specialty Public Health

Date 1994 Nov 1

PMID 7748650

Citations 4

Authors

N Johnson

D Mant

J Newton

P L Yudkin

Affiliations

Soon will be listed here.

Abstract

One of the targets for health in the United Kingdom is the reduction in the year-on-year increase in the incidence of skin cancer. Most of the mortality associated with skin cancer is attributable to malignant melanoma. One possible way to reduce the incidence of malignant melanoma is to develop a strategy for prevention based in primary care. This paper considers the arguments for and against three possible strategies: giving general advice; identifying patients at high risk; and undertaking early diagnosis. It is concluded that elements of all three strategies are likely to prove useful, but that major studies need to be undertaken before any strategy is adopted on a national basis.

Citing Articles

Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis.

Voss R, Woods T, Cromwell K, Nelson K, Cormier J Patient Relat Outcome Meas. 2015; 6:229-42.

PMID: 26609248 PMC: 4644158. DOI: 10.2147/PROM.S69351.

Screening for melanoma risk is misguided.

Keeley D BMJ. 1995; 310(6984):916.

PMID: 7719185 PMC: 2549295. DOI: 10.1136/bmj.310.6984.916.

Self screening for risk of melanoma: validity of self mole counting by patients in a single general practice.

Little P, Keefe M, White J BMJ. 1995; 310(6984):912-6.

PMID: 7719184 PMC: 2549294. DOI: 10.1136/bmj.310.6984.912.

Relationship between risk factors, knowledge and preventive behaviour relevant to skin cancer in general practice patients in south Australia.

Martin R Br J Gen Pract. 1995; 45(396):365-7.

PMID: 7612341 PMC: 1239300.

References

Cole P, MacMahon B . Attributable risk percent in case-control studies. Br J Prev Soc Med. 1971; 25(4):242-4. PMC: 478665. DOI: 10.1136/jech.25.4.242. View

Mackie R, Aitchison T . Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland. Br J Cancer. 1982; 46(6):955-60. PMC: 2011208. DOI: 10.1038/bjc.1982.307. View

Beral V, Evans S, Shaw H, MILTON G . Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol. 1983; 109(2):165-72. DOI: 10.1111/j.1365-2133.1983.tb07077.x. View

Elwood J, Gallagher R, Hill G, Spinelli J, Pearson J, Threlfall W . Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. Br Med J (Clin Res Ed). 1984; 288(6411):99-102. PMC: 1443966. DOI: 10.1136/bmj.288.6411.99. View

Green A, MACLENNAN R, Siskind V . Common acquired naevi and the risk of malignant melanoma. Int J Cancer. 1985; 35(3):297-300. DOI: 10.1002/ijc.2910350303. View

Nordlund J, Kirkwood J, Forget B, Scheibner A, Albert D, Lerner E . Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res. 1985; 45(4):1855-61. View

Elwood J, Williamson C, Stapleton P . Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources. Br J Cancer. 1986; 53(1):65-74. PMC: 2001477. DOI: 10.1038/bjc.1986.10. View

Holman C, Armstrong B, Heenan P . Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst. 1986; 76(3):403-14. View

Doherty V, Mackie R . Reasons for poor prognosis in British patients with cutaneous malignant melanoma. Br Med J (Clin Res Ed). 1986; 292(6526):987-9. PMC: 1339918. DOI: 10.1136/bmj.292.6526.987. View

10.

Swerdlow A, English J, Mackie R, ODoherty C, Hunter J, Clark J . Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed). 1986; 292(6535):1555-9. PMC: 1340558. DOI: 10.1136/bmj.292.6535.1555. View

11.

Holman C, Armstrong B, Heenan P, BLACKWELL J, Cumming F, English D . The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent Results Cancer Res. 1986; 102:18-37. DOI: 10.1007/978-3-642-82641-2_3. View

12.

Sober A . Solar exposure in the etiology of cutaneous melanoma. Photodermatol. 1987; 4(1):23-31. View

13.

Nichols S . Effect of a public campaign about malignant melanoma on general practitioner workload in Southampton. Br Med J (Clin Res Ed). 1988; 296(6635):1526. PMC: 2546033. View

14.

Osterlind A, Tucker M, HOU-JENSEN K, Stone B, Engholm G, JENSEN O . The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer. 1988; 42(2):200-6. DOI: 10.1002/ijc.2910420210. View

15.

Doherty V, Mackie R . Experience of a public education programme on early detection of cutaneous malignant melanoma. BMJ. 1988; 297(6645):388-91. PMC: 1834316. DOI: 10.1136/bmj.297.6645.388. View

16.

Mackie R, Freudenberger T, Aitchison T . Personal risk-factor chart for cutaneous melanoma. Lancet. 1989; 2(8661):487-90. DOI: 10.1016/s0140-6736(89)92097-7. View

17.

Whitehead S, Wroughton M, Elwood J, Davison J, Stewart M . Effects of a health education campaign for the earlier diagnosis of melanoma. Br J Cancer. 1989; 60(3):421-5. PMC: 2247174. DOI: 10.1038/bjc.1989.298. View

18.

Keefe M, Dick D, Wakeel R . A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma. Clin Exp Dermatol. 1990; 15(3):167-71. DOI: 10.1111/j.1365-2230.1990.tb02064.x. View

19.

Williams H, Smith D, Du Vivier A . Evaluation of public education campaigns in cutaneous melanoma: the King's College Hospital experience. Br J Dermatol. 1990; 123(1):85-92. DOI: 10.1111/j.1365-2133.1990.tb01827.x. View

20.

Mackie R . Clinical recognition of early invasive malignant melanoma. BMJ. 1990; 301(6759):1005-6. PMC: 1664014. DOI: 10.1136/bmj.301.6759.1005. View